Loading

Annals of Clinical Pathology

Community-Acquired Elizabethkingiameningoseptica with Leucine Aminopeptidase Activity as a Cause of Fatal Sepsis in an adult with Diabetes Mellitus

Research Article | Open Access | Volume 4 | Issue 1

  • 1. Department of Pathology and Laboratory Services, Altru Health System, USA
  • 2. Department of Pathology and Laboratory, Indiana University School of Medicine, USA
  • 3. Department of Pediatrics, University of Mississippi Medical Center, USA
+ Show More - Show Less
Corresponding Authors
Natalia I. Rush, Department of Pathology and Laboratory Services, Altru Health System, 350 W. 11th Street, Room 4014, Indianapolis, 46260, Indiana, USA, Tel: 317-491-6000; Fax: 317-491-6419
ABSTRACT

Elizabethkingiameningoseptica is an oxidase- and catalase-positive nonfermentative environmental saprophytic Gram-negative rod that can colonize medical devices and equipment due to its ability to form bio films, thus, resisting mechanical and chemical disinfection. This organism is usually associated with multi-drug resistant nosocomial infections. Here, we present a case of community-acquired E. meningoseptica in a 73-year-old man with multiple co morbidities, who presented with symptoms, signs, and laboratory data consistent with sepsis and multi-organ dysfunction syndrome. Initial cultures from blood and pleural fluid grew E. meningoseptica. Automated antimicrobial susceptibility tests demonstrated resistance to numerous drugs, except for fluoroquinolones. The patient’s antibiotic regimen was switched from broad spectrum to levofloxacin with nafcillin on day five of hospital stay. Although the patient cleared E. meningoseptica infection, he remained in critical condition and shortly developed nosocomial infections involving the urinary tract with Candida albicans and the respiratory tract with Stenotrophomonas maltophilia that led to death. In patients who present with severe sepsis caused by non-fermenting Gram-negative bacillus, E. meningoseptica should be considered, noting its multi-drug resistance and the potential for a dismal outcome.

KEYWORDS

Elizabethkingiameningoseptica, Community-acquired, Multi-drug resistance, Sepsis 

CITATION

Roiko MS, Rush NI, DeMoss P, Davis TE (2016) Community-Acquired Elizabethkingiameningoseptica with Leucine Aminopeptidase Activity as a Cause of Fatal Sepsis in an adult with Diabetes Mellitus. Ann Clin Pathol 4(1): 1057.

ABBREVIATIONS

E. meningoseptica: Elizabethkingiameningoseptica; rRNA: Ribosomal Ribonucleic Acid; ED: Emergency Department; PYR: Pyrrolidonyl Aminopeptidase; LAP: Leucine Aminopeptidase; KIA: Kligler Iron Agar

INTRODUCTION

E.meningosepticais an oxidase- and catalase-positive, nonfermentative, non-motile Gram-negative rod that is related to many other clinically significant members of the Bacteroidetes, including flavobacteria [1]. The organism has undergone considerable taxonomic revision, and it was previously called Flavobacterium meningosepticum (1959), Chryseobacterium meningosepticum (1994), and in 2005, it was renamed E.meningoseptica based on 16s rRNA phylogenetic analysis [1]. E. meningoseptica is ubiquitous in the environment and has been isolated from plants, soil and aquatic habitats [2]. Also, it has been identified to colonize medical devices and equipment, sinks, and even antiseptic solutions, predictably due to its ability to form bio films and resist mechanical and chemical disinfection [3-5]. Associated with its ability to readily colonize environmental surfaces of healthcare environments, infections caused by E. meningosepticum are typically contracted nosocomially or as a consequence of invasive proceduare. This organism is not considered to be part of the normal human flora; however, it has been isolated from asymptomatic patients [6,7].

CASE PRESENTATION

A 73-year-old male with poorly controlled type II diabetes presented to ED in septic shock and multi-organ dysfunction syndrome by ambulance. Prior to the paramedic’s arrival, the patient complained on a phone of diarrhea and shortness of breath without disclosure of his symptoms’ duration. Vital signs and physical examination obtained by the paramedics demonstrated dyspnea, hypotension, tachycardia, and altered mental status. Additional findings gathered in ED included dry mucous membranes and no breath sounds over the right chest. Significant initial laboratory values included serum creatinine of 7.14 mg/dL, pH of 7.27, bicarbonate of 12 mg/dL, albumin of 2.6 g/dL, neutrophilia (15,300 WBC: 88% neutrophils, 1% bands, 7% lymph and 4% monos), hemoglobin of 5.2 mg/ dL, and lactate of 6.5 mmol/L. The chest X-ray demonstrated a right pleural effusion. The patient was resuscitated with intravenous fluids, packed red blood cells, and was empirically treated with ceftriaxone and azithromycin. Respiratory and renal failures prompted transfer to the intensive care unit, where the antibiotic regimen was switched to vancomycin and piperacillin/ tazobactam. A review of the patient’s medical history revealed poorly-controlled diabetes mellitus type II, a stage II decubitus ulcer, obesity, chronic obstructive pulmonary disease, and laryngeal cancer, status post laryngectomy and tracheostomy in 1994.

An initial set of blood culture became positive 13 hours after collection. Gram’s stain demonstrated Gram-negative rods that were not identified by Gram-Negative Quick FISH™ (AdvanDx, Inc., Woburn, MA), a rapid method that permits identification of Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa from positive blood cultures. Following overnight incubation of blood culture aliquots on solid media in a CO2 - enriched atmosphere at 35° C, pale yellow colonies grew on 5% sheep blood agar and chocolate agar, but no growth was observed on Mac Conkey agar (Figure 1).

Overnight growth on brain heart infusion agar illustrates pale yellow colonies of E. meningoseptica.  B. Gram stain from overnight growth on sheep blood agar demonstrates straight and slightly- curved Gram-negative rods measuring 1-2 x 0.5 µm  (1000x original magnification).

Figure 1 A. Overnight growth on brain heart infusion agar illustrates pale yellow colonies of E. meningoseptica. B. Gram stain from overnight growth on sheep blood agar demonstrates straight and slightly- curved Gram-negative rods measuring 1-2 x 0.5 µm (1000x original magnification).

Roiko MS, Rush NI, DeMoss P, Davis TE (2016) Community-Acquired Elizabethkingiameningoseptica with Leucine Aminopeptidase Activity as a Cause of Fatal Sepsis in an adult with Diabetes Mellitus. Ann Clin Pathol 4(1): 1057.

The isolate was identified by VITEK®2 (bio Mérieux, Inc., Durham, NC) and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry as E. meningoseptica (Bruker Daltonics Inc., Billerica, MA). A summary of all microbiology studies are reported in Table 1. An automated antimicrobial susceptibility testing of this isolate demonstrated resistance to numerous drugs, except for fluoroquinolones (Vitek2, bio Merisux). A report of susceptibility testing is provided in Table 2. E. meningoseptica was also isolated from pleural fluid collected on the day after admission and demonstrated an equivalent antimicrobial susceptibility pattern. Cultures of a tracheal aspirate yielded methicillin-susceptible Staphylococcus aureus and a urine culture was negative. Subsequently, the patient’s antibiotic regimen was de-escalated to levofloxacin and nafcillin. While blood cultures from day 5 of hospital stay were still positive for E. meningoseptica, subsequent blood and pleural fluid cultures were negative. The patient remained in critical condition on vasopressors with signs of anoxic brain injury. On day 9, the patient had urine culture positive for >100,000 colony forming units of Candida albicans. On day 11, a sputum culture grew Stenotrophomonasmaltophilia. And on day 12, the patient had a blood culture positive for C. albicans in the aerobic bottle. The patient succumbed to his illness on hospital day 15.

DISCUSSION

Here we report a case of a community-acquired E. meningoseptica leading to fatal sepsis in an adult host. E. meningoseptica predominantly causes disease in two patient populations: infants and immune compromised. Infections are most often acquired from healthcare facilities, however, community-acquired meningitis and other disease presentations have been reported [5,7-13]. Although this patient’s initial presentation included altered mental status, which could have been related to meningitis, we have no evidence to support this. Upon admission, a cerebrospinal fluid specimen was not collected for laboratory analysis and, after the patient’s death; the family members declined an autopsy, which precluded acquisition of post-mortem evidence of meningitis.

Reported co morbidities in patients infected with E. meningoseptica include an immune compromised state, chronic debilitating diseases, including diabetes, malignancy, congestive heart failure, and invasive medical device placement, such as a central line or mechanical ventilator [5,8,9,14]. In this case, the patient had poorly-controlled type II diabetes with a tracheostomy and the stage II decubitus ulcer. However, it is not clear if the compromised barriers were a conduit for his infection, as the patient did not present with an active wound infection and there was no evidence for respiratory colonization, as a tracheal aspirate did not grow E. meningoseptica.

E. meningosepticais infrequently isolated in the clinical microbiology laboratory and may be challenging to identify. Key biochemical characteristics for this non-fermentative Gramnegative rod are positive oxidase, catalase, and indole reactions. Although the majority of E. meningoseptica strains grow on Mac Conkey agar, this isolate failed to do so, despite prolonged incubation. In addition to positivity for PYR and esculin hydrolysis by the Strep quick method (Hardy Diagnostics, Santa Maria, CA), the isolate was strongly positive for LAP, a result not previously reported.

Isolates of E. meningoseptica are frequently multi-drug resistant [14,15]. An antibiotic susceptibility testing for this organism should be performed by broth micro-dilution as disk diffusion methods may be erroneous [2,20]. Resistance to cephalosporins and carbapenems has been reported to be associated with serine and metallo-beta-lactamases, which may be chromosomally encoded [16-19]. E. meningosepticacan also acquire resistance to antibiotics, including resistance to erythromycin, rifampin, and sulfonamides [21-28]. In our case, the isolate was susceptible to fluoroquinolones.

No standard treatment guidelines have been developed for E. meningoseptica and the organism may not respond to antibiotics typically used for Gram-negative infections, such as beta-lactams, including carbapenems, and aminoglycosides [14]. Unusually, antibiotics for Gram-positive infections like fluoroquinolones, trimethoprim-sulfamethoxazole, vancomycin, and rifampin are effective [2,8,9,14,15,29,30]. Suggested antibiotic regimens include trimethoprim-sulfamethoxazole and fluoroquinolones, minocycline, or rifampin plus piperacillin [2,8,9,15,30]

Table 1: Summary of laboratory studies on E. meningoseptica isolate.

Test Result
Culture characteristics
Sheep blood agar Non-hemolytic
Mac Conkey agar No growth*
Pigment Pale yellow
Growth at 42°C No growth
Biochemical properties
Oxidase +
Catalase +
Indole +
DNase +
Gelatinase +
Pyrrolidonyl aminopeptidase +
Leucine aminopeptidase +**
Esculin hydrolysis +
Urease -
Motility -
Colistin Resistant
Kligler Iron Agar K/K
Carbohydrate substrate                                              Oxidation/Fermentation
Glucose +/-
Mannitol +/-
Xylose -/-
Lactose -/-
Sucrose +/-
Maltose +/-
Abbreviations: K/K = alkaline/alkaline; *Not characteristic finding; 
**Not previously reported

Table 2: Antimicrobial susceptibility.

Antibiotic MIC Interpretation
Amikacin >=64 R
Ampicillin/Sulbactam >=32 R
Cefepime >=64 R
Ceftazidime >=64 R
Ceftriaxone >=64 R
Ciprofloxacin 1 S
Gentamicin >=16 R
Levofloxacin 0.5 S
Meropenem >=16 R
Piperacillin/Tazobactam >=128 R
Tobramycin >=16 R
Trimethoprim/
Sulfamethoxazole
>=80 R
Abbreviations: MIC = Minimum Inhibitory Concentration
REFERENCES

1. Kim KK, Kim MK, Lim JH, Park HY, Lee ST. Transfer of Chryseobacterium meningosepticum and Chryseobacterium miricola to Elizabethkingia gen. nov. as Elizabethkingia meningoseptica comb. nov. and Elizabethkingia miricola comb. nov. Int J Syst Evol Microbiol. 2005; 55: 1287-1293.

2. Bloch KC, Nadarajah R, Jacobs R. Chryseobacterium meningosepticum: an emerging pathogen among immunocompromised adults. Report of 6 cases and literature review. Medicine (Baltimore). 1997; 76: 30-41.

3. Coyle-Gilchrist MM, Crewe P, Roberts G. Flavobacterium meningosepticum in the hospital environment. J Clin Pathol. 1976; 29: 824-826.

4. Ceyhan M, Celik M. Elizabethkingia meningosepticum (Chryseobacterium meningosepticum) Infections in Children. Int J Pediatr. 2011; 2011: 215237.

5. Ghafur A, Vidyalakshmi PR, Priyadarshini K, Easow JM, Raj R, Raja T. Elizabethkingia meningoseptica bacteremia in immunocompromised hosts: The first case series from India. South Asian J Cancer. 2013; 2: 211-215.

6. Olsen H, Ravn T. Flavobacterium meningosepticum isolated from the genitals. Acta Pathol Microbiol Scand B Microbiol Immunol. 1971; 79: 102-106.

7. Bagely DH Jr, Alexander JC Jr, Gill VJ, Dolin R, Ketcham AS. Late Flavobacterium species meningitis after craniofacial exenteration. Arch Intern Med. 1976; 136: 229-231.

8. Lin YT, Chiu CH, Chan YJ, Lin ML, Yu KW, Wang FD, et al. Clinical and microbiological analysis of Elizabethkingia meningoseptica bacteremia in adult patients in Taiwan. Scand J Infect Dis. 2009; 41: 628-634.

9. Hsu MS, Liao CH, Huang YT, Liu CY, Yang CJ, Kao KL, et al. Clinical features, antimicrobial susceptibilities, and outcomes of Elizabethkingia meningoseptica (Chryseobacterium meningosepticum) bacteremia at a medical center in Taiwan, 1999-2006. Eur J Clin Microbiol Infect Dis. 2011; 30: 1271-1278.

10. Uchihara T, Yokota T, Watabiki S, Ueki M, Miyake S, Tsukagoshi H. Flavobacterium meningosepticum meningitis in an adult. Am J Med. 1988; 85: 738-739.

11. Lu CH, Huang CR, Tsai NW, Chang CS, Chuang YC, Lee PY, et al. An adult case of Chryseobacterium meningosepticum meningitis. Jpn J Infect Dis. 2004; 57: 214-215.

12. Ozkalay N, Anil M, Agus N, Helvaci M, Sirti S. Community-acquired meningitis and sepsis caused by Chryseobacterium meningosepticum in a patient diagnosed with thalassemia major. J Clin Microbiol. 2006; 44: 3037-3039.

13. Hayek SS, Abd TT, Cribbs SK, Anderson AM, Melendez A, Kobayashi M, et al. Rare Elizabethkingia meningosepticum meningitis case in an immunocompetent adult. Emerg Microbes Infect. 2013; 2: e17.

14. Boroda K, Li L. Elizabethkingia meningosepticum in a Patient with Six-Year Bilateral Perma-Catheters. Case Rep Infect Dis. 2014; 2014: 985306.

15. Kirby JT, Sader HS, Walsh TR, Jones, RN. Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp: report from the SENTRY Antimicrobial Surveillance Program (1997- 2001). J Clin Mmicrobiol. 2004; 42: 445-448.

16. Yum JH, Lee EY, Hur SH, Jeong SH, Lee H, Yong D, et al. Genetic diversity of chromosomal metallo-beta-lactamase genes in clinical isolates of Elizabethkingia meningoseptica from Korea. J Microbiol. 2010; 48: 358-364.

17. Woodford N, Palepou MF, Babini GS, Holmes B, Livermore DM. Carbapenemases of Chryseobacterium (Flavobacterium) meningosepticum: distribution of blaB and characterization of a novel metallo-beta-lactamase gene, blaB3, in the type strain, NCTC 10016. Antimicrob Agents Chemother. 2000; 44: 1448-1452.

18. González LJ, Vila AJ. Carbapenem resistance in Elizabethkingia meningoseptica is mediated by metallo-β-lactamase BlaB. Antimicrob Agents Chemother. 2012; 56: 1686-1692.

19. Vessillier S, Docquier JD, Rival S, Frere JM, Galleni M, Amicosante G, et al. Overproduction and biochemical characterization of the Chryseobacterium meningosepticum BlaB metallo-beta-lactamase. Antimicrob Agents Chemother. 2002; 46: 1921-1927.

20. Fraser SL, Jorgensen JH. Reappraisal of the antimicrobial susceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing. Antimicrob Agents Chemother. 1997; 41: 2738-2741.

21. George RM, Cochran CP, Wheeler WE. Epidemic meningitis of the newborn caused by flavobacteria. II. Clinical manifestations and treatment. Am J Dis Child. 1961; 101: 296-304.

22. Hazuka BT, Dajani AS, Talbot K, Keen BM. Two outbreaks of Flavobacterium meningosepticum type E in a neonatal intensive care unit. J Clin Microbiol. 1977; 6: 450-455.

23. Rios I, Klimek JJ, Maderazo E, Quintiliani R. Flavobacterium meningosepticum meningitis: report of selected aspects. Antimicrob Agents Chemother. 1978; 14: 444-447.

24. Winslow DL, Pankey GA. Successful therapy with rifampin-Flavobacterium meningosepticum meningitis developing while on erythromycin therapy. Del Med J. 1982; 54: 575-579.

25. Abrahamsen TG, Finne PH, Lingaas E. Flavobacterium meningosepticum infections in a neonatal intensive care unit. Acta Paediatr Scand. 1989; 78: 51-55.

26. Ferlauto JJ, Wells DH. Flavobacterium meningosepticum in the neonatal period. South Med J. 1981; 74: 757-759.

27. Kelsey MC, Emmerson AM, Drabu Y. Flavobacterium meningosepticum ventriculitis: in vivo and in vitro results with the combinations rifampicin-erythromycin and mezlocillin-cefoxitin. Eur J Clin Microbiol. 1982; 1: 138-143.

28. Ratnamani MS, Rao R. Elizabethkingia meningoseptica: Emerging nosocomial pathogen in bedside hemodialysis patients. Indian J Crit Care Med. 2013; 17: 304-307.

29. Dias M, Fernandes A, Furtado Z. Case series: elizabethkingia meningosepticum. J Clin Diagn Res. 2012; 6: 1550-1551.

30. Issack MI, Neetoo Y. An outbreak of Elizabethkingia meningoseptica neonatal meningitis in Mauritius. J Infect Dev Ctries. 2011; 5: 834-839.

Roiko MS, Rush NI, DeMoss P, Davis TE (2016) Community-Acquired Elizabethkingiameningoseptica with Leucine Aminopeptidase Activity as a Cause of Fatal Sepsis in an adult with Diabetes Mellitus. Ann Clin Pathol 4(1): 1057.

Received : 06 Nov 2015
Accepted : 15 Nov 2015
Published : 16 Nov 2015
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X